Key Benefits * Helps improve glycemic control in adults with Type 2 diabetes when used with diet and exercise * Supports weight management in adults with obesity or overweight with at least one weightrelated comorbidity * Enhances insulin secretion and assists in lowering blood glucose levels * Slows gastric emptying to help reduce appetite and food intake * Onceweekly subcutaneous injection offers convenience and encourages adherence * Used under specialist supervision as part of a comprehensive metabolic treatment plan Price 21,400/Pen 25,781/Pen Save 17% off MRP Dosage 12.5mg Pack Size 1 Prefilled Pen of 2.4ml Manufacturer CIPLA LTD Active Ingredient Tirzepatide Category Diabetes Division Frequently Asked Questions What is Yurpeak 12.5mg Injection for
Symptomatic heart rate increases or new cardiovascular symptoms warrant prompt medical evaluation
[7] [17] Gastrointestinal side effects including nausea, vomiting, diarrhea, constipation, and abdominal discomfort affect 2050% of patients, particularly during dose escalation periods
In the other 730 cases, no malignant tumor could be found on histological examination
And dont let the boring name scare you off
Scientists use FOXO4-DRI in research studies
